Published in J Lipids on July 18, 2011
The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res (2013) 1.06
AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver. PLoS One (2015) 0.84
Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001-2002, a Cross-Sectional, Hypothesis-Generating Study. Biomark Insights (2011) 0.83
Association Between Thyroid Hormones, Lipids and Oxidative Stress Markers in Subclinical Hypothyroidism. J Med Biochem (2015) 0.79
Oxidized LDL Is Strictly Limited to Hyperthyroidism Irrespective of Fat Feeding in Female Sprague Dawley Rats. Int J Mol Sci (2015) 0.77
Newborn screening for autism: in search of candidate biomarkers. Biomark Med (2013) 0.77
The impact of high fat diets on physiological changes in euthyroid and thyroid altered rats. Lipids Health Dis (2013) 0.76
Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging Dis (2013) 0.76
Association of apolipoprotein b/apolipoprotein A1 ratio and coronary artery stenosis and plaques detected by multi-detector computed tomography in healthy population. J Korean Med Sci (2013) 0.75
Daily versus alternate day thyroxine therapy to maintain euthyroidism in children with congenital hypothyroidism. Int J Endocrinol Metab (2013) 0.75
Serum Lipid Transfer Proteins in Hypothyreotic Patients Are Inversely Correlated with Thyroid-Stimulating Hormone (TSH) Levels. Med Sci Monit (2016) 0.75
The effect of iron supplement on children with euthyroid goiter: a randomized placebo-controlled clinical trial. Iran J Ped Hematol Oncol (2014) 0.75
Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer. J Int Med Res (2016) 0.75
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab (2002) 13.06
Thyroid hormone and the cardiovascular system. N Engl J Med (2001) 5.56
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med (2008) 3.20
The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab (2008) 2.35
Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf) (1993) 2.00
Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med (1992) 1.99
Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J (1977) 1.94
Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol (2007) 1.88
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol (2009) 1.77
Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res (2004) 1.67
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest (1974) 1.66
Thyroid diseases and cerebrovascular disease. Stroke (2005) 1.63
Hypothyroidism as a risk factor for cardiovascular disease. Endocrine (2004) 1.61
Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf) (1995) 1.61
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab (2004) 1.59
The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab (2010) 1.58
Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med (2004) 1.57
Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis (2003) 1.55
Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab (1997) 1.55
Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab (2000) 1.49
Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis (2001) 1.43
Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J (2005) 1.43
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Thyroid (2003) 1.40
Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid (2008) 1.38
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab (2001) 1.37
Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid (2002) 1.37
Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab (2006) 1.36
Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med (2006) 1.32
Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab (2007) 1.32
Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) (2004) 1.30
New insights into regulation of lipid metabolism by thyroid hormone. Curr Opin Endocrinol Diabetes Obes (2010) 1.28
Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol (2010) 1.28
Thyroid function and carotid wall thickness. J Clin Endocrinol Metab (2004) 1.23
Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab (2009) 1.22
Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med (2006) 1.22
Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol (Oxf) (2008) 1.19
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab (2002) 1.15
Myxedema and coronary artery disease--a comparative autopsy study. Ann Intern Med (1968) 1.14
Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev (1985) 1.13
Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study. Stroke (2010) 1.12
Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol (2010) 1.09
The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J (2010) 1.06
Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) (2007) 1.06
Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab (2001) 1.04
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J Endocrinol (2001) 1.04
Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med (2003) 1.04
Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol (2010) 1.04
Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther (2008) 1.04
Regulation of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice. Endocrinology (2003) 1.04
Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis (2005) 1.03
Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf) (2005) 1.02
Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med (1981) 1.02
A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens (2009) 1.02
Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid (2000) 1.02
Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch Intern Med (1990) 1.00
Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol (Oxf) (2006) 1.00
Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among metabolic syndrome parameters. J Endocrinol Invest (2010) 1.00
Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med (2010) 0.98
Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. J Lipid Res (1981) 0.97
The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest (1997) 0.97
Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res (2008) 0.97
The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf) (1997) 0.96
Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab (2006) 0.96
Thyrotoxicosis and coronary artery spasm: case report and review of the literature. Angiology (2010) 0.95
Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem (1995) 0.94
Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab (2005) 0.93
Regression of the increased common carotid artery-intima media thickness in subclinical hypothyroidism after thyroid hormone replacement. Endocr J (2009) 0.93
Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich) (2006) 0.92
Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc Health Risk Manag (2006) 0.92
Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol (1998) 0.92
Hypothyroidism as a protective factor in acute stroke patients. Clin Endocrinol (Oxf) (2006) 0.91
Hypothyroidism as a cause of hypertension. Hypertension (1983) 0.91
Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein. J Clin Endocrinol Metab (1998) 0.90
Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events. Endocr Pract (2003) 0.89
Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocr J (2009) 0.89
Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol (2005) 0.89
Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy. Angiology (2003) 0.89
Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clin Endocrinol (Oxf) (2004) 0.88
Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Intern Med (1994) 0.88
Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Clin Endocrinol (Oxf) (2008) 0.88
Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab (1993) 0.87
Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy. Clin Nutr (1999) 0.87
Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism (1998) 0.87
Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters. Clin Endocrinol (Oxf) (2009) 0.86
Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab (2009) 0.86
High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment. Q J Med (1986) 0.86
Cholesterol 7 alpha-hydroxylase activity in hypothyroidism and hyperthyroidism in humans. Horm Metab Res (1997) 0.86
Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study. Eur J Endocrinol (2009) 0.86
Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab (2001) 0.86
Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf) (1990) 0.86
Free thyroxine index and risk of stroke: results from the National Health and Nutrition Examination Survey Follow-up Study. Med Sci Monit (2006) 0.85
Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. Mayo Clin Proc (1998) 0.85
Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice. Metabolism (2001) 0.85
Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin Chem Lab Med (2008) 0.84
Subclinical hypothyroidism, hyperhomocysteinemia and dyslipidemia: investigating links with ischemic stroke in Turkish patients. Neurol Res (2007) 0.84
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression. Endocrinology (2008) 0.84
Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha. Eur J Endocrinol (2009) 0.83
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol (2009) 1.77
Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes. Leuk Res (2012) 1.48
Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma. Clin Cancer Res (2009) 1.12
Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity. Am J Clin Nutr (2009) 1.09
Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovasc Diabetol (2010) 1.08
Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr Opin Clin Nutr Metab Care (2007) 1.06
Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol (2010) 1.04
Pathways and targets in hepatocellular carcinoma. Expert Rev Anticancer Ther (2012) 0.99
Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr Rev (2010) 0.99
Lifestyle intervention favorably affects weight loss and maintenance following obesity surgery. Obesity (Silver Spring) (2009) 0.98
Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine (2010) 0.98
A modified technique of retrograde intubation dacryocystorhinostomy for proximal canalicular obstruction. Clin Ophthalmol (2009) 0.94
Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours. Endocr Relat Cancer (2012) 0.92
Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc Diabetol (2011) 0.91
Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck. Head Neck Pathol (2012) 0.90
Coexistence of differentiated thyroid carcinoma with primary thyroid lymphoma in a background of Hashimoto's thyroiditis. J Clin Oncol (2011) 0.90
Dasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation. Leuk Res (2012) 0.89
Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens (2012) 0.88
Awareness and attitudes of Greek medical students on colorectal cancer screening. World J Gastrointest Endosc (2012) 0.87
Rates of glucose uptake in adipose tissue and muscle in vivo after a mixed meal in women with morbid obesity. J Clin Endocrinol Metab (2009) 0.87
Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. Cardiovasc Diabetol (2011) 0.87
Diagnostic dilemmas in atypical postinfectious glomerulonephritis. Semin Diagn Pathol (2002) 0.86
Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes. Epigenetics (2013) 0.84
Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha. Eur J Endocrinol (2009) 0.83
Partially hydrolyzed guar gum accelerates colonic transit time and improves symptoms in adults with chronic constipation. Dig Dis Sci (2014) 0.83
Thyroid disease in older people. Maturitas (2011) 0.82
Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol (2014) 0.82
Metabolic syndrome and cardiometabolic risk factors. Curr Vasc Pharmacol (2013) 0.82
High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int (2012) 0.82
Increases in muscle blood flow after a mixed meal are impaired at all stages of type 2 diabetes. Clin Endocrinol (Oxf) (2012) 0.80
Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis. Intensive Care Med (2012) 0.80
An adolescent with a rare midline neck tumor: thyroid carcinoma in a thyroglossal duct cyst. J Pediatr Hematol Oncol (2014) 0.79
Microdialysis-assessed interstitium alterations during sepsis: relationship to stage, infection, and pathogen. Intensive Care Med (2011) 0.79
Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int (2015) 0.78
A pleomorphic rhabdomyosarcoma mimicking an inguinal hernia: a case report and review of the literature. Case Rep Oncol (2012) 0.78
Vinegar decreases postprandial hyperglycemia in patients with type 1 diabetes. Diabetes Care (2010) 0.78
Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.77
The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: new insights. Int J Psychiatry Clin Pract (2012) 0.77
Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. Exp Diabetes Res (2011) 0.77
Epigenetics in gastrointestinal stromal tumors: clinical implications and potential therapeutic perspectives. Dig Dis Sci (2013) 0.77
Primary mucosa-associated lymphoid tissue thyroid lymphoma: a rare thyroid neoplasm of extrathyroid origin. Rare Tumors (2012) 0.75
Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Front Oncol (2013) 0.75
An unusual case of prolonged post-endoscopic retrograde cholangiopancreatography jaundice. Hepatobiliary Pancreat Dis Int (2016) 0.75
Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the 'real life' setting: A single center observational study. Hematology (2015) 0.75
Insulin action in morbid obesity: a focus on muscle and adipose tissue. Hormones (Athens) (2013) 0.75
Causes of impaired delivery of hemodialysis prescription. Artif Organs (2006) 0.75
Severe hyperinsulinemia, decreased GLUT3 and GLUT4 expression, and increased retinol binding protein 4 in a patient with chronic graft-versus-host disease post bone marrow transplantation. Pediatr Transplant (2011) 0.75
Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: outcomes of prolonged therapy. Leuk Res (2011) 0.75
Rhabdomyolysis and acute kidney injury after acupuncture sessions. Saudi J Kidney Dis Transpl (2014) 0.75
The role of adiponectin as a compensatory mediator for the primary secretory defect in latent autoimmune diabetes in adults. Clin Ther (2013) 0.75